The AT1 Receptor Blocker Telmisartan Reduces Intestinal Mucus Thickness in Obese Mice

The angiotensin II (type 1) (AT(1)) receptor blocker telmisartan (TEL) is beneficial for the treatment of individuals suffering from metabolic syndrome. As we have shown that TEL has an impact on gut microbiota, we investigated here whether TEL influences gut barrier function. C57BL/6N mice were fed...

Descripción completa

Detalles Bibliográficos
Autores principales: Nickel, Laura, Sünderhauf, Annika, Rawish, Elias, Stölting, Ines, Derer, Stefanie, Thorns, Christoph, Matschl, Urte, Othman, Alaa, Sina, Christian, Raasch, Walter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009210/
https://www.ncbi.nlm.nih.gov/pubmed/35431918
http://dx.doi.org/10.3389/fphar.2022.815353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009210/
https://www.ncbi.nlm.nih.gov/pubmed/35431918
http://dx.doi.org/10.3389/fphar.2022.815353

Ejemplares similares